ABBV and BMY Related Headlines
Go Back- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
- Leerink highlights drug demand rebound after Memorial Day
- RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
- Barclays launches U.S. biopharma coverage with four preferred picks
- Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight
- Bernstein on IRA pricing: $245 really is the floor
